Description
Peripheral blood mononuclear cells (PBMCs) from the same patient before and after receiving an FDA-approved COVID-19 vaccine.

Peripheral blood mononuclear cells (PBMCs) from the same patient before and after receiving an FDA-approved COVID-19 vaccine.